The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Migraine Disorders, Migraine Headache, Migraine, Acute Migraine

In brief

The purpose of this study is to evaluate the efficacy and safety of intra-oral topical ketoprofen for the treatment of acute migraine.

Key facts

Study ID

NCT01228552

Run by

Behar, Caren, M.D.

People needed

100

Starts

2011-12-01

Expected to finish

2012-01-01

Last updated by the study team

2011-06-08

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Established diagnosis of Migraine as per IHS with aura
• Established diagnosis of Migraine as per IHS without aura
• At least 2 migraines per month
• At least 18 years of age

You may not qualify if…

• Pregnancy or Lactation
• Other Headache Conditions including basilar, hemiplegic, or ophthalmoplegic migraines
• Chronic Daily Headache
• Allergy or Sensitivity to NSAIDs
• Other Severe Medical Conditions including GI bleeding, blood dyscrasias, thrombocytopenia

Where it is running

• New York Medical College — Valhalla, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.